MEDLAB CLINICAL LIMITED - Announcements

Market Cap $15.07M Add to my watchlist

Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

MDC	Proposed issue of securities - MDC		14/09/21	26.56KB	Share
MDC	Notice of Annual General Meeting/Proxy Form		14/09/21	705.25KB	Share
MDC	MDC Presentation - Update and Future Initiatives		03/09/21	3.23MB	Share
MDC	Appendix 4G		31/08/21	272.2KB	Share
MDC	Corporate Governance Statement		31/08/21	176.95KB	Share
MDC	Appendix 4E	PRICE SENSITIVE	31/08/21	80.88KB	Share
MDC	Annual Report to shareholders		31/08/21	9.79MB	Share
MDC	MDC Receives Approval for NanaBis PIII Trials from the TGA		25/08/21	201.93KB	Share
MDC	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	263.47KB	Share
MDC	US Patent Office issues Notice of Allowance for NRGBiotic	PRICE SENSITIVE	27/07/21	227.1KB	Share
MDC	Medlab executes Master Services Agreement with WEP Clinical	PRICE SENSITIVE	19/07/21	222.11KB	Share
MDC	Australian Ethics Grants Approval for NanaBis PIII AUS Sites	PRICE SENSITIVE	12/07/21	207.28KB	Share
MDC	CommSec Correction to Medlab Directors Selling Shares		09/07/21	211.96KB	Share
MDC	Initial Director's Interest Notice		09/07/21	192.3KB	Share
MDC	Medlab NRGBiotic Depression Study Results	PRICE SENSITIVE	05/07/21	215.8KB	Share
MDC	Notification regarding unquoted securities - MDC		29/06/21	30.51KB	Share
MDC	Proposed issue of securities - MDC		28/06/21	29.55KB	Share
MDC	European and Canadian Patent Offices Grant NanoCelle Patents	PRICE SENSITIVE	23/06/21	189.68KB	Share
MDC	Medlab Presenting - LD Micro Invitational XI Conference 2021		07/06/21	225.07KB	Share
MDC	Addendum to Appendix 4C		04/06/21	201.14KB	Share
MDC	Jefferies Healthcare Conference Presentation		02/06/21	3.22MB	Share
MDC	Jefferies Healthcare Conference Webcast Link		27/05/21	158.79KB	Share
MDC	Synthetic formulation in pending global PIII Trial	PRICE SENSITIVE	20/05/21	169.38KB	Share
MDC	Medlab Presenting at Jefferies Global Healthcare Conference		13/05/21	205.83KB	Share
MDC	Appointment of CFO & Company Secretary		13/05/21	224.88KB	Share
MDC	Notice under Section 708A(5)(e) of the Corporations Act		05/05/21	60.29KB	Share
MDC	Notice under Section 708A(5)(e) of the Corporations Act		05/05/21	61.22KB	Share
MDC	Appendix 2A		30/04/21	286.23KB	Share
MDC	Appendix 2A		30/04/21	271.52KB	Share
MDC	Appendix 2A		29/04/21	274.43KB	Share
MDC	Results of Meeting		26/04/21	218.65KB	Share
MDC	Chairman's Address to Shareholders		26/04/21	548.62KB	Share
MDC	Reminder of Investor Webinar - NanaBis Phase III Trial		22/04/21	5.36MB	Share
MDC	Appendix 4C - monthly	PRICE SENSITIVE	20/04/21	391.69KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	20/04/21	301.67KB	Share
MDC	NanaBis Observational Study progress update		12/04/21	219.81KB	Share
MDC	Notification of Investor Webinar - NanaBis Phase III Trial		08/04/21	164.78KB	Share
MDC	Intention to Grant EU Notice NanoCelle	PRICE SENSITIVE	07/04/21	198.02KB	Share
MDC	Executive and Management changes		31/03/21	155.09KB	Share
MDC	Ceasing to be a substantial holder x 2		29/03/21	214.48KB	Share
MDC	Change in substantial holding		29/03/21	109.42KB	Share
MDC	Notice under Section 708A(5)(e) of the Corporations Act		29/03/21	34.44KB	Share
MDC	Notice of Extraordinary General Meeting/Proxy Form		26/03/21	515.55KB	Share
MDC	Appendix 2A		23/03/21	485.19KB	Share
MDC	Leading Pharmaceutical Executive joins Medlab Board		19/03/21	162.27KB	Share
MDC	Proposed issue of Securities - MDC		19/03/21	25.25KB	Share
MDC	Proposed issue of Securities - MDC		19/03/21	25.43KB	Share
MDC	Successful Completion of $15 million Placement	PRICE SENSITIVE	19/03/21	665.25KB	Share
MDC	Trading Halt	PRICE SENSITIVE	17/03/21	753.71KB	Share
MDC	Pause in Trading	PRICE SENSITIVE	17/03/21	115.1KB	Share
MDC	Half Yearly Report and Accounts		24/02/21	1.9MB	Share
MDC	Appendix 4D	PRICE SENSITIVE	24/02/21	1.1MB	Share
MDC	HOA with Arrotex to accelerate NanoCB access for Pharmacy	PRICE SENSITIVE	18/02/21	661.16KB	Share
MDC	Medlab Receives Positive Depression Trial Prelim Results	PRICE SENSITIVE	11/02/21	877.6KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	25/01/21	1.45MB	Share
MDC	Corporate Update		20/01/21	8.9MB	Share
MDC	NanaBis IND Presentation - Webinar		19/01/21	1.05MB	Share
MDC	FDA Grants an IND for NanaBis and Investor Webcast	PRICE SENSITIVE	19/01/21	1.11MB	Share
MDC	Change of Director's Interest Notice		30/12/20	1.54MB	Share
MDC	2020 Research Program Update		09/12/20	859.44KB	Share
MDC	NanaBis Observational Study Progression Report		30/11/20	847.02KB	Share
MDC	Appendix 3Y x 4		12/11/20	3.06MB	Share
MDC	Appendix 3G		12/11/20	482.78KB	Share
MDC	Proposed issue of Securities - MDC		12/11/20	27.6KB	Share
MDC	Proposed issue of Securities - MDC		12/11/20	27.6KB	Share
MDC	NanaBis P3 Trial Launching in the UK with support from NIHR	PRICE SENSITIVE	11/11/20	804.33KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/20	3.14MB	Share
MDC	Results of Meeting		16/10/20	676.43KB	Share
MDC	AGM Presentation		16/10/20	7.79MB	Share
MDC	Attendance at AGM		12/10/20	551.47KB	Share
MDC	Medlab to Present at Key US Investor Conferences		01/10/20	6.26MB	Share
MDC	Australian Patent Granted for NanoCelle Delivery Platform	PRICE SENSITIVE	23/09/20	1.03MB	Share
MDC	NanaBis Investor Presentation		21/09/20	8.17MB	Share
MDC	Notice of Annual General Meeting/Proxy Form		15/09/20	1.04MB	Share
MDC	Medlab Signs CRO for NanaBis Phase III Trial		01/09/20	800.61KB	Share
MDC	Corporate Governance Statement		28/08/20	456.36KB	Share
MDC	Appendix 4G		28/08/20	605.78KB	Share
MDC	Appendix 4E	PRICE SENSITIVE	28/08/20	1.07MB	Share
MDC	Annual Report to shareholders		28/08/20	10.76MB	Share
MDC	Medlab to Present at Sharecafe Hidden Gems Webinar		27/08/20	741.33KB	Share
MDC	Initial Director's Interest Notice		05/08/20	777.81KB	Share
MDC	Director Appointment/Resignation		05/08/20	635.47KB	Share
MDC	Presentation - Stockpal Biotech and Healthcare Webinar		04/08/20	3.45MB	Share
MDC	NanaBis Observational Study Progress Update		03/08/20	776.81KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/20	1.67MB	Share
MDC	Section 708A Cleansing Notice		09/07/20	343.92KB	Share
MDC	Appendix 2A		08/07/20	484.57KB	Share
MDC	Completion of SPP		08/07/20	720.26KB	Share
MDC	Invitation to Virtual Research Symposium		07/07/20	680.61KB	Share
MDC	Lapse of Unlisted Options		01/07/20	647.71KB	Share
MDC	Medlab Completes First Order of New Cannabinoid to UK	PRICE SENSITIVE	29/06/20	696.83KB	Share
MDC	Reminder - Medlab Shareholder Video Conference		26/06/20	673.67KB	Share
MDC	Change in substantial holding x 3		22/06/20	1.44MB	Share
MDC	Section 708A Cleansing Notice		22/06/20	765.67KB	Share
MDC	Appendix 2A		18/06/20	484.96KB	Share
MDC	Share Purchase Plan and Invitation to Shareholder Update		17/06/20	1.18MB	Share
MDC	Section 708A Cleansing Notice		16/06/20	900.06KB	Share
MDC	Proposed issue of Securities - MDC	PRICE SENSITIVE	15/06/20	34.54KB	Share
MDC	Medlab Completes Successful $5.4m Placement	PRICE SENSITIVE	15/06/20	726.61KB	Share
MDC	NanoCBD Delivery Received and First Patient Supplied	PRICE SENSITIVE	11/06/20	836KB	Share

MDC Proposed issue of securities - MDC
14/09/21		26.56KB	Share
MDC Notice of Annual General Meeting/Proxy Form
14/09/21		705.25KB	Share
MDC MDC Presentation - Update and Future Initiatives
03/09/21		3.23MB	Share
MDC Appendix 4G
31/08/21		272.2KB	Share
MDC Corporate Governance Statement
31/08/21		176.95KB	Share
MDC Appendix 4E
31/08/21	PRICE SENSITIVE	80.88KB	Share
MDC Annual Report to shareholders
31/08/21		9.79MB	Share
MDC MDC Receives Approval for NanaBis PIII Trials from the TGA
25/08/21		201.93KB	Share
MDC Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	263.47KB	Share
MDC US Patent Office issues Notice of Allowance for NRGBiotic
27/07/21	PRICE SENSITIVE	227.1KB	Share
MDC Medlab executes Master Services Agreement with WEP Clinical
19/07/21	PRICE SENSITIVE	222.11KB	Share
MDC Australian Ethics Grants Approval for NanaBis PIII AUS Sites
12/07/21	PRICE SENSITIVE	207.28KB	Share
MDC CommSec Correction to Medlab Directors Selling Shares
09/07/21		211.96KB	Share
MDC Initial Director's Interest Notice
09/07/21		192.3KB	Share
MDC Medlab NRGBiotic Depression Study Results
05/07/21	PRICE SENSITIVE	215.8KB	Share
MDC Notification regarding unquoted securities - MDC
29/06/21		30.51KB	Share
MDC Proposed issue of securities - MDC
28/06/21		29.55KB	Share
MDC European and Canadian Patent Offices Grant NanoCelle Patents
23/06/21	PRICE SENSITIVE	189.68KB	Share
MDC Medlab Presenting - LD Micro Invitational XI Conference 2021
07/06/21		225.07KB	Share
MDC Addendum to Appendix 4C
04/06/21		201.14KB	Share
MDC Jefferies Healthcare Conference Presentation
02/06/21		3.22MB	Share
MDC Jefferies Healthcare Conference Webcast Link
27/05/21		158.79KB	Share
MDC Synthetic formulation in pending global PIII Trial
20/05/21	PRICE SENSITIVE	169.38KB	Share
MDC Medlab Presenting at Jefferies Global Healthcare Conference
13/05/21		205.83KB	Share
MDC Appointment of CFO & Company Secretary
13/05/21		224.88KB	Share
MDC Notice under Section 708A(5)(e) of the Corporations Act
05/05/21		60.29KB	Share
MDC Notice under Section 708A(5)(e) of the Corporations Act
05/05/21		61.22KB	Share
MDC Appendix 2A
30/04/21		286.23KB	Share
MDC Appendix 2A
30/04/21		271.52KB	Share
MDC Appendix 2A
29/04/21		274.43KB	Share
MDC Results of Meeting
26/04/21		218.65KB	Share
MDC Chairman's Address to Shareholders
26/04/21		548.62KB	Share
MDC Reminder of Investor Webinar - NanaBis Phase III Trial
22/04/21		5.36MB	Share
MDC Appendix 4C - monthly
20/04/21	PRICE SENSITIVE	391.69KB	Share
MDC Appendix 4C - quarterly
20/04/21	PRICE SENSITIVE	301.67KB	Share
MDC NanaBis Observational Study progress update
12/04/21		219.81KB	Share
MDC Notification of Investor Webinar - NanaBis Phase III Trial
08/04/21		164.78KB	Share
MDC Intention to Grant EU Notice NanoCelle
07/04/21	PRICE SENSITIVE	198.02KB	Share
MDC Executive and Management changes
31/03/21		155.09KB	Share
MDC Ceasing to be a substantial holder x 2
29/03/21		214.48KB	Share
MDC Change in substantial holding
29/03/21		109.42KB	Share
MDC Notice under Section 708A(5)(e) of the Corporations Act
29/03/21		34.44KB	Share
MDC Notice of Extraordinary General Meeting/Proxy Form
26/03/21		515.55KB	Share
MDC Appendix 2A
23/03/21		485.19KB	Share
MDC Leading Pharmaceutical Executive joins Medlab Board
19/03/21		162.27KB	Share
MDC Proposed issue of Securities - MDC
19/03/21		25.25KB	Share
MDC Proposed issue of Securities - MDC
19/03/21		25.43KB	Share
MDC Successful Completion of $15 million Placement
19/03/21	PRICE SENSITIVE	665.25KB	Share
MDC Trading Halt
17/03/21	PRICE SENSITIVE	753.71KB	Share
MDC Pause in Trading
17/03/21	PRICE SENSITIVE	115.1KB	Share
MDC Half Yearly Report and Accounts
24/02/21		1.9MB	Share
MDC Appendix 4D
24/02/21	PRICE SENSITIVE	1.1MB	Share
MDC HOA with Arrotex to accelerate NanoCB access for Pharmacy
18/02/21	PRICE SENSITIVE	661.16KB	Share
MDC Medlab Receives Positive Depression Trial Prelim Results
11/02/21	PRICE SENSITIVE	877.6KB	Share
MDC Appendix 4C - quarterly
25/01/21	PRICE SENSITIVE	1.45MB	Share
MDC Corporate Update
20/01/21		8.9MB	Share
MDC NanaBis IND Presentation - Webinar
19/01/21		1.05MB	Share
MDC FDA Grants an IND for NanaBis and Investor Webcast
19/01/21	PRICE SENSITIVE	1.11MB	Share
MDC Change of Director's Interest Notice
30/12/20		1.54MB	Share
MDC 2020 Research Program Update
09/12/20		859.44KB	Share
MDC NanaBis Observational Study Progression Report
30/11/20		847.02KB	Share
MDC Appendix 3Y x 4
12/11/20		3.06MB	Share
MDC Appendix 3G
12/11/20		482.78KB	Share
MDC Proposed issue of Securities - MDC
12/11/20		27.6KB	Share
MDC Proposed issue of Securities - MDC
12/11/20		27.6KB	Share
MDC NanaBis P3 Trial Launching in the UK with support from NIHR
11/11/20	PRICE SENSITIVE	804.33KB	Share
MDC Appendix 4C - quarterly
28/10/20	PRICE SENSITIVE	3.14MB	Share
MDC Results of Meeting
16/10/20		676.43KB	Share
MDC AGM Presentation
16/10/20		7.79MB	Share
MDC Attendance at AGM
12/10/20		551.47KB	Share
MDC Medlab to Present at Key US Investor Conferences
01/10/20		6.26MB	Share
MDC Australian Patent Granted for NanoCelle Delivery Platform
23/09/20	PRICE SENSITIVE	1.03MB	Share
MDC NanaBis Investor Presentation
21/09/20		8.17MB	Share
MDC Notice of Annual General Meeting/Proxy Form
15/09/20		1.04MB	Share
MDC Medlab Signs CRO for NanaBis Phase III Trial
01/09/20		800.61KB	Share
MDC Corporate Governance Statement
28/08/20		456.36KB	Share
MDC Appendix 4G
28/08/20		605.78KB	Share
MDC Appendix 4E
28/08/20	PRICE SENSITIVE	1.07MB	Share
MDC Annual Report to shareholders
28/08/20		10.76MB	Share
MDC Medlab to Present at Sharecafe Hidden Gems Webinar
27/08/20		741.33KB	Share
MDC Initial Director's Interest Notice
05/08/20		777.81KB	Share
MDC Director Appointment/Resignation
05/08/20		635.47KB	Share
MDC Presentation - Stockpal Biotech and Healthcare Webinar
04/08/20		3.45MB	Share
MDC NanaBis Observational Study Progress Update
03/08/20		776.81KB	Share
MDC Appendix 4C - quarterly
30/07/20	PRICE SENSITIVE	1.67MB	Share
MDC Section 708A Cleansing Notice
09/07/20		343.92KB	Share
MDC Appendix 2A
08/07/20		484.57KB	Share
MDC Completion of SPP
08/07/20		720.26KB	Share
MDC Invitation to Virtual Research Symposium
07/07/20		680.61KB	Share
MDC Lapse of Unlisted Options
01/07/20		647.71KB	Share
MDC Medlab Completes First Order of New Cannabinoid to UK
29/06/20	PRICE SENSITIVE	696.83KB	Share
MDC Reminder - Medlab Shareholder Video Conference
26/06/20		673.67KB	Share
MDC Change in substantial holding x 3
22/06/20		1.44MB	Share
MDC Section 708A Cleansing Notice
22/06/20		765.67KB	Share
MDC Appendix 2A
18/06/20		484.96KB	Share
MDC Share Purchase Plan and Invitation to Shareholder Update
17/06/20		1.18MB	Share
MDC Section 708A Cleansing Notice
16/06/20		900.06KB	Share
MDC Proposed issue of Securities - MDC
15/06/20	PRICE SENSITIVE	34.54KB	Share
MDC Medlab Completes Successful $5.4m Placement
15/06/20	PRICE SENSITIVE	726.61KB	Share
MDC NanoCBD Delivery Received and First Patient Supplied
11/06/20	PRICE SENSITIVE	836KB	Share

REFRESH

First 2 3 4

(20min delay)
Last $6.60		Change 0.000(0.00%)		Mkt cap ! $15.07M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

MDC (ASX) Chart

Day chart unavailable

MEDLAB CLINICAL LIMITED - Announcements

Announcements

Top Stories